As we all know, there is a phase in the development of this pathology that makes its course fatal: when tumor cells multiply and spread to other organs, creating metastases, it is almost impossible to face and win the battle for a patient's survival. Waisman's recent studies have identified in this process the direct responsibilities of a protein, S100A10, present on the surface of macrophages, the cells responsible for the body's immune defense.
The action of this protein, in practice, would 'break the barriers' between the tumor and the body's healthy cells, allowing its spread throughout the body. Understanding how S100A10 works (this is the next step in this research which could lead to truly definitive and historic results) could lead to the development of drugs capable of inhibiting its action, thus preventing the creation of metastases.
The results of this experimental study were also observed on guinea pigs: comparing two mice, one with and one with a deficiency of S100A10 (unfortunately inoculated with fibrosarcomas to proceed with the study), the mouse with deficiency of the key protein presented, after washing peritoneal and analysis of collected macrophages, the absence of cancer proliferation and regression of the injected tumor tissue.
It is possible to expect man's victory over Cancer: it is not a question of IF, but WHEN. A future is not far away in which, struck by a tumor, anyone will be able to keep it at bay like a hernia or a chronic discomfort, simply by taking a drug.
Today we arm ourselves with more patience, and with new hope.
